Clinical Trial Update: Safety and Dose-finding Study of DC-TAB in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and dose-finding study of DC-TAB in healthy subjects to assess safety and tolerability related to Multiple Sclerosis, sponsored by Delta Crystall…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• DC-TAB

Snippet

Sponsor: Delta Crystallon BV | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED